QQQ   352.50 (+1.05%)
AAPL   179.14 (+0.74%)
MSFT   326.17 (+0.86%)
META   266.69 (+1.17%)
GOOGL   122.76 (+0.21%)
AMZN   125.15 (+3.23%)
TSLA   232.33 (+3.46%)
NVDA   384.53 (+2.61%)
NIO   7.68 (-1.03%)
BABA   86.89 (+1.89%)
AMD   121.25 (+2.90%)
T   15.93 (-1.06%)
F   13.50 (-0.66%)
MU   65.10 (-2.92%)
CGC   0.70 (-2.56%)
GE   106.95 (+0.82%)
DIS   92.04 (-0.52%)
AMC   4.60 (-2.75%)
PFE   39.03 (+0.36%)
PYPL   64.49 (+0.70%)
NFLX   405.54 (+1.44%)
QQQ   352.50 (+1.05%)
AAPL   179.14 (+0.74%)
MSFT   326.17 (+0.86%)
META   266.69 (+1.17%)
GOOGL   122.76 (+0.21%)
AMZN   125.15 (+3.23%)
TSLA   232.33 (+3.46%)
NVDA   384.53 (+2.61%)
NIO   7.68 (-1.03%)
BABA   86.89 (+1.89%)
AMD   121.25 (+2.90%)
T   15.93 (-1.06%)
F   13.50 (-0.66%)
MU   65.10 (-2.92%)
CGC   0.70 (-2.56%)
GE   106.95 (+0.82%)
DIS   92.04 (-0.52%)
AMC   4.60 (-2.75%)
PFE   39.03 (+0.36%)
PYPL   64.49 (+0.70%)
NFLX   405.54 (+1.44%)
QQQ   352.50 (+1.05%)
AAPL   179.14 (+0.74%)
MSFT   326.17 (+0.86%)
META   266.69 (+1.17%)
GOOGL   122.76 (+0.21%)
AMZN   125.15 (+3.23%)
TSLA   232.33 (+3.46%)
NVDA   384.53 (+2.61%)
NIO   7.68 (-1.03%)
BABA   86.89 (+1.89%)
AMD   121.25 (+2.90%)
T   15.93 (-1.06%)
F   13.50 (-0.66%)
MU   65.10 (-2.92%)
CGC   0.70 (-2.56%)
GE   106.95 (+0.82%)
DIS   92.04 (-0.52%)
AMC   4.60 (-2.75%)
PFE   39.03 (+0.36%)
PYPL   64.49 (+0.70%)
NFLX   405.54 (+1.44%)
QQQ   352.50 (+1.05%)
AAPL   179.14 (+0.74%)
MSFT   326.17 (+0.86%)
META   266.69 (+1.17%)
GOOGL   122.76 (+0.21%)
AMZN   125.15 (+3.23%)
TSLA   232.33 (+3.46%)
NVDA   384.53 (+2.61%)
NIO   7.68 (-1.03%)
BABA   86.89 (+1.89%)
AMD   121.25 (+2.90%)
T   15.93 (-1.06%)
F   13.50 (-0.66%)
MU   65.10 (-2.92%)
CGC   0.70 (-2.56%)
GE   106.95 (+0.82%)
DIS   92.04 (-0.52%)
AMC   4.60 (-2.75%)
PFE   39.03 (+0.36%)
PYPL   64.49 (+0.70%)
NFLX   405.54 (+1.44%)
NYSE:QGEN

Qiagen (QGEN) Stock Forecast, Price & News

$45.60
+0.68 (+1.51%)
(As of 11:16 AM ET)
Compare
Today's Range
$44.74
$45.60
50-Day Range
$43.93
$46.76
52-Week Range
$40.38
$51.18
Volume
215,481 shs
Average Volume
763,323 shs
Market Capitalization
$10.38 billion
P/E Ratio
29.61
Dividend Yield
N/A
Price Target
$54.87

Qiagen MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
21.6% Upside
$54.87 Price Target
Short Interest
Healthy
1.27% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.83
Upright™ Environmental Score
News Sentiment
0.37mentions of Qiagen in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.55%
From $2.12 to $2.28 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.49 out of 5 stars

Medical Sector

128th out of 981 stocks

Biological Products, Except Diagnostic Industry

20th out of 165 stocks


QGEN stock logo

About Qiagen (NYSE:QGEN) Stock

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Receive QGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Qiagen and its competitors with MarketBeat's FREE daily newsletter.

QGEN Stock News Headlines

Qiagen (QGEN) Receives a Hold from Jefferies
Graphite Shortage Could Derail the $7 Trillion EV Transition
Graphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.
Qiagen (QGEN) Receives a Hold from UBS
3 Medical Stocks Rated BUY
Kepler Capital Keeps Their Hold Rating on Qiagen (QGEN)
The Real Problem With "Made in America" Lithium
Politicians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple.
Qiagen (NYSE:QGEN) Upgraded by Morgan Stanley to Overweight
StockNews.com Initiates Coverage on Qiagen (NASDAQ:QGEN)
QGEN Qiagen N.V.
Qiagen NV QGEN Stock Quote
Qiagen (QGEN) Q1 Earnings Beat Estimates
(QGEN) & Its Rivals Head-To-Head Review
QIAGEN announces expansion of Supervisory Board
See More Headlines

QGEN Price History

QGEN Company Calendar

Last Earnings
5/03/2023
Today
6/08/2023
Next Earnings (Estimated)
7/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Employees
6,178
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$54.87
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+22.1%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$423.21 million
Pretax Margin
21.31%

Debt

Sales & Book Value

Annual Sales
$2.14 billion
Cash Flow
$3.40 per share
Book Value
$15.22 per share

Miscellaneous

Free Float
207,222,000
Market Cap
$10.24 billion
Optionable
Optionable
Beta
0.38

Key Executives

  • Thierry Bernard
    Chief Executive Officer & Managing Director
  • Antonio Santos
    Senior Vice President & Head-Global Operations
  • Roland Sackers
    Chief Financial Officer & Managing Director
  • Philipp von Hugo
    VP, Head-Global Legal Affairs & Compliance
  • Lezette Young
    Manager-Compliance & Legal













QGEN Stock - Frequently Asked Questions

Should I buy or sell Qiagen stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Qiagen in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" QGEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QGEN, but not buy additional shares or sell existing shares.
View QGEN analyst ratings
or view top-rated stocks.

What is Qiagen's stock price forecast for 2023?

5 equities research analysts have issued twelve-month target prices for Qiagen's stock. Their QGEN share price forecasts range from $50.00 to $60.00. On average, they anticipate the company's share price to reach $54.87 in the next year. This suggests a possible upside of 22.1% from the stock's current price.
View analysts price targets for QGEN
or view top-rated stocks among Wall Street analysts.

How have QGEN shares performed in 2023?

Qiagen's stock was trading at $49.87 at the start of the year. Since then, QGEN shares have decreased by 9.9% and is now trading at $44.95.
View the best growth stocks for 2023 here
.

Are investors shorting Qiagen?

Qiagen saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 3,130,000 shares, a drop of 20.6% from the April 15th total of 3,940,000 shares. Based on an average daily trading volume, of 779,200 shares, the days-to-cover ratio is currently 4.0 days. Currently, 1.4% of the shares of the company are short sold.
View Qiagen's Short Interest
.

When is Qiagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023.
View our QGEN earnings forecast
.

How were Qiagen's earnings last quarter?

Qiagen (NYSE:QGEN) released its quarterly earnings data on Wednesday, May, 3rd. The company reported $0.51 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.04. The firm had revenue of $485.40 million for the quarter, compared to the consensus estimate of $478.23 million. Qiagen had a net margin of 17.66% and a trailing twelve-month return on equity of 14.08%. The company's revenue was down 22.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.80 earnings per share.

What guidance has Qiagen issued on next quarter's earnings?

Qiagen issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of $2.10- for the period, compared to the consensus EPS estimate of $2.10. The company issued revenue guidance of $2.05B-, compared to the consensus revenue estimate of $2.06 billion.

What is Thierry Bernard's approval rating as Qiagen's CEO?

33 employees have rated Qiagen Chief Executive Officer Thierry Bernard on Glassdoor.com. Thierry Bernard has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Qiagen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Qiagen investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Gilead Sciences (GILD), Advanced Micro Devices (AMD), PayPal (PYPL), Netflix (NFLX), Pfizer (PFE), Cisco Systems (CSCO), Amgen (AMGN) and Lam Research (LRCX).

What is Qiagen's stock symbol?

Qiagen trades on the New York Stock Exchange (NYSE) under the ticker symbol "QGEN."

Who are Qiagen's major shareholders?

Qiagen's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.36%), FIL Ltd (1.35%), DekaBank Deutsche Girozentrale (1.27%), Perpetual Ltd (1.23%), Arrowstreet Capital Limited Partnership (1.22%) and Wellington Management Group LLP (1.21%).

How do I buy shares of Qiagen?

Shares of QGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Qiagen's stock price today?

One share of QGEN stock can currently be purchased for approximately $44.95.

How much money does Qiagen make?

Qiagen (NYSE:QGEN) has a market capitalization of $10.24 billion and generates $2.14 billion in revenue each year. The company earns $423.21 million in net income (profit) each year or $1.54 on an earnings per share basis.

How many employees does Qiagen have?

The company employs 6,178 workers across the globe.

How can I contact Qiagen?

Qiagen's mailing address is HULSTERWEG 82, VENLO P7, 5912. The official website for the company is www.qiagen.com. The company can be reached via phone at (177) 355-6600, via email at ir@qiagen.com, or via fax at 31-77-355-6658.

This page (NYSE:QGEN) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -